USE OF EXEMESTANE FOR THE TREATMENT OF GASTRIC CANCER

Title:

USE OF EXEMESTANE FOR THE TREATMENT OF GASTRIC CANCER

Document Type and Number:

WIPO Patent Application WO/2018/041050

Kind Code:

A1

Abstract:

Gastric cancer is treated with an aromatase irreversible steroidal inhibitor such as exemestane and derivatives thereof. The methods may further comprise the antecedent step of identifying the person as having gastric cancer and/or being in need of exemestane therapy, and/or the subsequent step of monitoring status of the gastric cancer or a biomarker thereof.

More Like This:

WO/1999/063973	PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3$g(b),17$g(b)-DIOL
JP3803540	USE OF DHEA OR PRECURSOR OR METABOLITE DERIVATIVE THEREOF AS DECORATION AGENT
JP2023553469	11-LC-MS method for detecting and quantifying oxygenated steroids

Inventors:

MA WEN-LUNG (TW)

Application Number:

PCT/CN2017/099180

Publication Date:

March 08, 2018

Filing Date:

August 25, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV CHINA MEDICAL (CN)

International Classes:

A61K31/5685; A61K31/17; A61K31/337; A61K31/407; A61K31/513; A61K31/704; A61K31/7068; A61K33/243; A61P35/00

Foreign References:

CN105209068A	2015-12-30
US20160193357A1	2016-07-07
CN1729002A	2006-02-01

Download PDF:

View/Download PDF PDF Help

Previous Patent: INFORMATION PROCESSING METHOD, TERMINAL, SERVER AND COMPUTER STORAGE MEDIUM

Next Patent: THREE-STAGE VARIABLE COLOR PASTE PUMP AND OPERATION METHOD THEREFOR